<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">Ayu</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22661843</article-id><article-id pub-id-type="pmc">3361924</article-id><article-id pub-id-type="publisher-id">Ayu-32-494</article-id><article-id pub-id-type="doi">10.4103/0974-8520.96122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>A comparative clinical trial of <italic>Chincha kshara</italic> and <italic>Kadali kshara</italic> on <italic>Amlapitta</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Acharya</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Panda</surname><given-names>P. K.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Acharya</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mohanty</surname><given-names>N.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Nathsharma</surname><given-names>P. K.</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Dash</surname><given-names>S. C.</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Lecturer, Rasashastra and Bhaishaya Kalpana, Govt. Ayurvedic College, Balangir, Odisha, India</aff><aff id="aff2"><label>2</label>Reader and Head, Roga Nidana, Govt. Ayurvedic College, Balangir, Odisha, India</aff><aff id="aff3"><label>3</label>Lecturer, Dravyaguna, Govt. Ayurvedic College, Balangir, Odisha, India</aff><aff id="aff4"><label>4</label>Professor and Head, Rasashastra and Bhaishaya Kalpana, Govt. Ayurvedic College, Raipur, Chhattisgarh, India</aff><aff id="aff5"><label>5</label>Professor and Head, Dravyaguna, Principal, K.A.T.S. Ayurvedic College, Ankushpur, Ganjam, Orissa, India</aff><aff id="aff6"><label>6</label>Programme Director, International Centre for Ayurvedic Studies, Gujarat Ayurved University, Jamnagar, Gujarat, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. P. K. Panda, Reader, Department of Roga Nidana, Government Ayurveda College, Balangir, Orissa, India. E-mail: <email xlink:href="drpkpandanidan@rediffmail.com">drpkpandanidan@rediffmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2011</year></pub-date><volume>32</volume><issue>4</issue><fpage>494</fpage><lpage>499</lpage><permissions><copyright-statement>Copyright: &#x000a9; AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>A clinical trial was carried out on 30 patients of Amlapitta aged between 20 to 35 years with complaints of <italic>Avipaka</italic>, <italic>hrit-kanthadaha</italic>, <italic>tikta-amlodgara</italic>, <italic>utklesa, udarasula, adhmana</italic> and <italic>aruchi</italic>, who were registered from OPD and IPD of Gopabandhu Ayurveda Mahavidyalaya, Puri. They were equally divided into three groups <italic>Chincha kshara, Kadali kshara</italic> and placebo (who were administered with fresh wheat powder) for 30 days in a dose of 500 mg thrice daily with water. Investigations was done in order to exclude upper gastrointestinal tract ulcer, carcinoma in stomach, cholecystitis, carcinoma gall bladder, and heart diseases. The clinical assessments were carried out on the 30<sup>th</sup> day by subjective and objective parameters and it was inferred that both <italic>Chincha kshara</italic> and <italic>Kadali kshara</italic> were effective and reduced the symptoms of amlapitta. <italic>Chincha kshara</italic> was found to be more effective than <italic>Kadali kshara</italic>. The study shows the effect of <italic>Chincha</italic> and <italic>Kadali kshara</italic> which led to cure in 4(40%) and 3(30%) patients respectively, and maximum improvement in 4(40%) and 5(50%) patients affected with amlapitta disease, respectively. No untoward effect was noticed due to administration of <italic>ksharas</italic> during the clinical trial period.</p></abstract><kwd-group><kwd>Adhmana</kwd><kwd><italic>Amlapitta</italic></kwd><kwd><italic>Chincha kshara</italic></kwd><kwd><italic>Kadali kshara</italic></kwd><kwd><italic>Udarasula</italic></kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>Introduction</title><p>Since time immemorial, India has been endowed with a fairly well-established medical science of its own with rich and genuine materia medica.[<xref ref-type="bibr" rid="ref1">1</xref>] The treatment knowledge is empirical and obtained by trial and error methods. Today, drugs which are used in medicines are scientifically evaluated and they are either obtained from natural sources or are of synthetic origins. Natural drugs are procured from plants, animals and mineral origins.[<xref ref-type="bibr" rid="ref2">2</xref>]</p><p><italic>Ksharas</italic>, a type of Ayurvedic medicine of plant origin, are prepared out of the dried plant ashes by a special process known as <italic>kshara kalpana</italic>.[<xref ref-type="bibr" rid="ref3">3</xref>] Since the period of Samhita, <italic>ksharas</italic> have been used in the treatment of many diseases. <italic>Ksharas</italic> have the qualities[<xref ref-type="bibr" rid="ref4">4</xref>] of <italic>tikshna, natimridu, ushna, laghu, ruksha, pichhila</italic>,[<xref ref-type="bibr" rid="ref5">5</xref>] <italic>seta</italic> and <italic>shukla</italic>. They possess <italic>Deepana</italic>,[<xref ref-type="bibr" rid="ref6">6</xref>] <italic>pachana, chhedana</italic>, pacify <italic>tridosa</italic>, clears srotas and destroy the <italic>krimis</italic>.[<xref ref-type="bibr" rid="ref7">7</xref>] Taste of <italic>kshara</italic> is <italic>pancharasa</italic> being <italic>lavana</italic> as <italic>anurasa</italic> and devoid of <italic>amlarasa</italic>.[<xref ref-type="bibr" rid="ref8">8</xref>] By asserting the real state of <italic>dosas</italic>, an efficient physician with <italic>kshara</italic> expertise can well treat the patients suffering from <italic>amlapitta</italic>,[<xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref10">10</xref>] <italic>grahani, sula, gulma</italic>,[<xref ref-type="bibr" rid="ref11">11</xref>] <italic>mandagni</italic>, piles, fistula-in-ano[<xref ref-type="bibr" rid="ref7">7</xref>] and <italic>adhimansa</italic> Judicious administration and application of <italic>kshara</italic>, will always give benefit with full satisfaction.</p><p><italic>Amlapitta</italic>, may be caused due to irregular food habits and abuse of certain analgesic drugs.</p><p>Keeping the above under consideration, a random sample of 30 patients were of <italic>Amlapitta</italic> studied, to evaluate the efficacy of trial drugs. They were equally divided into three groups, and were administered with <italic>Chincha kshara, Kadali kshra</italic> and fresh wheat powder as placebo, respectively.</p><sec id="sec2-1"><title>Aim and objective</title><p>This study was carried out to evaluate the efficacy of the <italic>Chincha kshara</italic> and <italic>Kadali kshara</italic> and to compare the drug effect on <italic>Amlapitta</italic>.</p></sec></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-2"><title>Selection of patients</title><p>Thirty patients of <italic>Amlapitta</italic> with age between 20&#x02013;45 years of both sexes were enrolled from OPD and IPD of Gopabandhu Ayurveda Mahavidyalaya, Puri. Detailed history, complete general and systemic examination and required pathological investigations were done.</p><p>Inclusion criteria for selection of patients were <italic>avipaka</italic> (indigestion), <italic>hrit-kanthadaha</italic> (heart burn), <italic>tikta-amlaudgara</italic> (acid eructation), <italic>utklesa</italic> (nausea), <italic>vamana</italic> (vomiting), <italic>udarasula</italic> (abdominal pain), and <italic>adhmana</italic> (flatulence), <italic>klama</italic> (tiredness) and <italic>aruchi</italic> (anorexia).</p><p>The exclusion criteria was <italic>Nila-krushnaraktavamana</italic> (bile-blood vomiting), <italic>murchha</italic> (syncope), <italic>angapitata</italic> (yellow coloration of body), <italic>krushna-raktamalasarana</italic> (black and blood letting stool), <italic>amasayavrana</italic> (stomach ulcer), <italic>grahanivrana</italic> (duodenal ulcer), <italic>garbhavasta</italic> (pregnancy), lactation, cancer in stomach, <italic>pittasayaasmari</italic> (cholelithiasis) and patients suffering from acid peptic disease for more than 3 years.</p><p>Thirty patients were randomly grouped into three groups. Each group consisted of 10 patients and the groups were named as group C, K and P. They were administered with <italic>Chincha kshara</italic> (group C), <italic>Kadali kshara</italic>(group K) and fried wheat powder as placebo (group P) in a dose of 500 mg, respectively, thrice daily with water after food for 30 days. Normal diet devoid of excess <italic>amla, lavana</italic> and <italic>katu rasa</italic> was advised. The required pathological investigations were conducted on the day of entry and on 30<sup>th</sup> day of the clinical study in all the selected patients and recorded for clinical evaluation.</p></sec><sec id="sec2-3"><title>Selection of drug</title><p>Classical references impart a very clear concept of the therapeutic use of <italic>kshara</italic> on internal application.[<xref ref-type="bibr" rid="ref12">12</xref>] When <italic>amla</italic> is predominant,[<xref ref-type="bibr" rid="ref8">8</xref>] <italic>kshara</italic> is said to be like <italic>agni</italic>[<xref ref-type="bibr" rid="ref4">4</xref>] and is caustic. It enhances the digestive power by which indigestion, heart burn, acid eructation, nausea and vomiting like symptoms of <italic>Amlapitta</italic> will be subsided. Considering this the <italic>kshara</italic> preparations were included in the clinical study.</p><p>The <italic>Chincha</italic> (tamarind)[<xref ref-type="bibr" rid="ref13">13</xref>] and <italic>Kadali</italic> (plantain)[<xref ref-type="bibr" rid="ref14">14</xref>] are mentioned under <italic>phalavarga</italic> in classical texts, and the <italic>kshara</italic> prepared[<xref ref-type="bibr" rid="ref15">15</xref>] out of the tamarind bark and leaves of plantain is advocated in the treatment of <italic>gulma, ajeerna, mandagni, amlapitta, adhmana</italic>, etc.[<xref ref-type="bibr" rid="ref16">16</xref>] The physico-chemical analysis of <italic>chincha kshara</italic> and <italic>kadali kshara</italic> was done at Regional Research Laboratory, Bhubaneswar, to identify the pH, specific gravity, alkalinity and associated elements [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Physico-chemical analysis of <italic>Chincha kshara</italic> and <italic>Kadali kshara</italic></p></caption><graphic xlink:href="Ayu-32-494-g001"/></table-wrap></sec><sec id="sec2-4"><title>Investigations done</title><p>Hemoglobin (Hb) estimation in gm%, stool examination and upper gastrointestinal endoscopy were done for each patient on the first and last day of the clinical trial.</p></sec><sec id="sec2-5"><title>Assessment</title><p>Subjective and objective Parameters &#x02013; were used for the assessment of treatment. The objective parameters were Hb%, stool examination and upper gastrointestinal endoscopy. Assessment was made by grading as 0, 1, 2, and 3 on the basis of severity and duration of symptoms and favorable shift to left.</p></sec><sec id="sec2-6"><title>Evaluation of response</title><p>In view of the changes in the clinical features, the grading was done as follows:</p><p>
<list list-type="bullet"><list-item><p>Complete cure 100%: Free from chief complaint [<italic>avipaka</italic> (indigestion), <italic>hrit-kanthadaha</italic> (heart burn), <italic>tikta-amlaudgara</italic> (acid eructation), <italic>utklesa</italic> (nausea), <italic>vamana</italic> (vomiting), <italic>udarasula</italic> (abdominal pain), <italic>adhmana</italic> (flatulence), <italic>klama</italic> (tiredness) and <italic>aruchi</italic> (anorexia)].</p></list-item><list-item><p>Maximum improvement: From 75 to &#x0003c;100% improvement of the clinical features.</p></list-item><list-item><p>Moderate improvement: From 50 to &#x0003c;75% improvement of the clinical features.</p></list-item><list-item><p>Mild improvement: From 25 to &#x0003c;50% improvement of the clinical features.</p></list-item><list-item><p>No improvement: &#x0003c;25% or no improvement in both subjective and objective parameters.</p></list-item></list>
</p></sec></sec><sec id="sec1-3"><title>Observation and Results</title><p>It was observed from age wise distribution of patients that those of age within 20&#x02013;29 years were more (56.66%) affected [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The distribution of patients according to age</p></caption><graphic xlink:href="Ayu-32-494-g002"/></table-wrap><p>Majority of the enrolled patients were males (70%) and the females formed 30% [<xref ref-type="table" rid="T3">Table 3</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>The distribution of patients according to sex</p></caption><graphic xlink:href="Ayu-32-494-g003"/></table-wrap><p>Maximum number of patients were found to have up to primary education (50%), followed by those with secondary education (26.66%) and +2 level or above (23.33%) [<xref ref-type="table" rid="T4">Table 4</xref>].</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>The distribution of patients according to education</p></caption><graphic xlink:href="Ayu-32-494-g004"/></table-wrap><p>The socioeconomic status of the enrolled patients revealed the maximum percentage of them to be present in poor-income group (70%) as compared to the number in middle-income group (23.33%) and high-income group (6.66%) [<xref ref-type="table" rid="T5">Table 5</xref>].</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>The distribution of patients according to socioeconomic status</p></caption><graphic xlink:href="Ayu-32-494-g005"/></table-wrap><p>Based on the occupation, it is found that the prevalence of disease is more (43.33%) in the labor class followed by businessmen (20%), office workers and housewives (13% each) and students (10%) [<xref ref-type="table" rid="T6">Table 6</xref>].</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>The distribution of patients according to occupation</p></caption><graphic xlink:href="Ayu-32-494-g006"/></table-wrap><p>Classification of patients according to <italic>ahara</italic> (dietary factor) showed that <italic>amlarasadhikya ahara</italic> (86.66%) consuming patients were the maximum affected, followed by <italic>vidahi</italic> (63.33), and <italic>abhisyandhibhojana</italic>(10%) <italic>ahara</italic> consuming patients were the least affected [<xref ref-type="table" rid="T7">Table 7</xref>].</p><table-wrap id="T7" position="float"><label>Table 7</label><caption><p>The distribution of patients according to <italic>ahara</italic> (dietary factor)</p></caption><graphic xlink:href="Ayu-32-494-g007"/></table-wrap><p>Classification of patients according to <italic>vihara</italic> showed that they were habituated with <italic>atapasevana</italic> (60%) instead of <italic>divaswapna</italic> (20%) and <italic>vegadharana</italic> (20%) [<xref ref-type="table" rid="T8">Table 8</xref>].</p><table-wrap id="T8" position="float"><label>Table 8</label><caption><p>The distribution of patients according to <italic>vihara</italic></p></caption><graphic xlink:href="Ayu-32-494-g008"/></table-wrap><p><xref ref-type="table" rid="T9">Table 9</xref> shows that more than 60% patients were addicted to tea/coffee, followed by tobacco (23.33%) and alcohol (16.66%).</p><table-wrap id="T9" position="float"><label>Table 9</label><caption><p>The distribution of patients according to addiction</p></caption><graphic xlink:href="Ayu-32-494-g009"/></table-wrap><p>The distribution of patients according to their <italic>prakriti</italic> shows 53.33% belonging to <italic>vatapittaja</italic>, whereas 43.33% were of <italic>vatakaphaja</italic> and the remaining 3.33% were <italic>pittakaphaja</italic> [<xref ref-type="table" rid="T10">Table 10</xref>].</p><table-wrap id="T10" position="float"><label>Table 10</label><caption><p>The distribution of patients according to <italic>prakriti</italic></p></caption><graphic xlink:href="Ayu-32-494-g010"/></table-wrap><p>The classification of patients according to the <italic>kostha</italic> indicated that that 50% of the patients were in <italic>mridukostha</italic>, and among them 60% of cases had <italic>mandagni</italic> followed by 36.66% and 13.33% were of <italic>madya</italic> and <italic>krura kostha</italic> respectively [<xref ref-type="table" rid="T11">Table 11</xref>].</p><table-wrap id="T11" position="float"><label>Table 11</label><caption><p>The distribution of patients according to <italic>kostha</italic></p></caption><graphic xlink:href="Ayu-32-494-g011"/></table-wrap><p>Symptoms like <italic>hrit-kanthadaha</italic>, <italic>tikta-amlaudgara</italic> were found 100% in each group of patients, whereas <italic>avipaka</italic> was found in 100%, 90% and 80% patients in group C, K, and P, respectively. <italic>Aruchi</italic> and <italic>klama</italic> were found in 90% patients in group C, but they were present in 80% patients in the placebo group, and in 90% and 70% patients, respectively, in group K.</p><p>The symptoms of <italic>utklesa</italic>, <italic>udarasula</italic> and <italic>Adhamana</italic> were found within 60&#x02013;80% of cases in the different groups. In upper gastrointestinal endoscopy, 90% patients were affected in groups C and P, whereas 80% patients were affected in group K [<xref ref-type="table" rid="T12">Table 12</xref>].</p><table-wrap id="T12" position="float"><label>Table 12</label><caption><p>The incidence of clinical features (<italic>n</italic>=10 in each group)</p></caption><graphic xlink:href="Ayu-32-494-g012"/></table-wrap><p>After assessment, it was found that in group C, 04(40%) patients were cured and 04(40%) patients showed maximum improvement, whereas in group K, 03(30%) and 05(50%) patients were in the stage of cure and maximum improvement, respectively. One patient (10%) each was in mild and moderate improvement stages in group C and K. But in the placebo group, 08 (80%) patients did not responded to the clinical trial and mild and moderate improvement was seen only in one patient each [<xref ref-type="table" rid="T13">Table 13</xref>].</p><table-wrap id="T13" position="float"><label>Table 13</label><caption><p>The clinical assessment of results of different groups (<italic>n</italic>=10 in each group)</p></caption><graphic xlink:href="Ayu-32-494-g013"/></table-wrap><p>Statistical analysis showed that both the drugs <italic>chincha</italic> and <italic>kadalikshara</italic> reduced the symptoms of <italic>avipaka</italic>(indigestion), <italic>hrit-kanthadaha</italic> (heart burn), <italic>tikta-amlaudgara</italic> (acid eructation), <italic>utklesa</italic> (nausea), <italic>adhmana</italic> (flatulence), <italic>klama</italic> (tiredness) and <italic>aruchi</italic> (anorexia) significantly with <italic>P</italic>&#x0003c;0.001, whereas in placebo group, it was not significant (<italic>P</italic>&#x0003e;0.05). Improvement of the symptoms like udarasula (abdominal pain) was also found to be significant with both trial drugs (<italic>P</italic>&#x0003c;0.01), but no improvement was found in the placebo group. Hb in each group was increased, but the increase was not satisfactory. The endoscopy revealed that degree of gastritis was reduced in group C (<italic>P</italic>&#x0003c;0.05) and group K (<italic>P</italic>&#x0003c;0.05), whereas unsatisfactory result (<italic>P</italic>&#x0003e;0.05) was obtained in the placebo group [<xref ref-type="table" rid="T14">Table 14</xref>].</p><table-wrap id="T14" position="float"><label>Table 14</label><caption><p>The effectiveness of clinical trial drugs on symptoms (<italic>n</italic>=10 in each group)</p></caption><graphic xlink:href="Ayu-32-494-g014"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>The <italic>kshara</italic> preparations have been used since the time of Charaka[<xref ref-type="bibr" rid="ref16">16</xref>] and Sushruta[<xref ref-type="bibr" rid="ref3">3</xref>] in diseases related to gastrointestinal system such as <italic>amlapitta, gluma, sula</italic>, etc. It is an applied fact that <italic>kshara</italic> gets neutralized in combination with <italic>amla</italic>. Five <italic>rasas</italic> are present in <italic>kshara</italic> except <italic>amla</italic>. <italic>Lavana rasa</italic>, being <italic>anurasa</italic>, is converted to <italic>madhura</italic> when mixed with <italic>amla</italic>. So, the <italic>teekshna guna</italic> of <italic>lavana rasa</italic> present in <italic>kshara</italic> is neutralized due to its combination with <italic>amla</italic> as the water extinguishes the fire.[<xref ref-type="bibr" rid="ref17">17</xref>]</p><p>Maximum patients enrolled in the clinical study were in the age group of 20&#x02013;29 years (55.66%) and among them, males formed 70%. Maximum number of patients had up to primary education (50%) and were in the poor-income group (70%) and labor class(43.33%).</p><p>During the assessment of clinical symptoms, it is found that patients were more exposed to <italic>atapasevana</italic> (60%) and their intake habits were <italic>pittavardhaka</italic> (100%), <italic>amlarasadhikya</italic> (86.66%) and <italic>vidahiannaahara</italic> (63.83%). They were suffering from <italic>agnimandya</italic> due to <italic>mridukostha</italic> (50%) or were addicted to tea and coffee (60%).</p><p>Among the main symptoms of <italic>amlapitta</italic>, <italic>hrit-kanthadaha</italic> and <italic>tikta-amlaudgara</italic> were found in all the patients (100%) of each group and other symptoms like <italic>avipaka, utklesha, aruchi</italic>, <italic>udarasula</italic> and <italic>adhmana</italic> were also seen in 60&#x02013;90% patients <italic>Chincha kshara</italic> and <italic>Kadali kshara</italic> cured 04(40%) and 03(30%) patients, respectively, and maximum improvement was seen in 04(40%) and 05(50%) patients, respectively. Unsatisfactory (80%) result was obtained with the placebo drug.</p><p>Statistical analysis inferred that <italic>avipaka</italic> (indigestion), <italic>hrit-kanthadaha</italic> (heart burn), <italic>tikta-amlaudgara</italic> (acid eructation), <italic>utklesa</italic> (nausea), <italic>adhmana</italic> (flatulence), <italic>klama</italic> (tiredness) and <italic>aruchi</italic> (anorexia) were statistically reduced (<italic>P</italic>&#x0003c;0.001), but reduction in <italic>udarasula</italic> was less statistically significant as compared to the aforesaid symptoms [<xref ref-type="table" rid="T14">Table 14</xref>]. No improvement was detected in the placebo group patients (<italic>P</italic>&#x0003e;0.05). It is also found that the signs of gastritis was reduced satisfactorily in group C (<italic>P</italic>&#x0003c;0.05) and group K (<italic>P</italic>&#x0003c;0.05), but was unsatisfactory in the placebo group (<italic>P</italic>&#x0003e;0.05).</p><p>This clinical study reveals that both <italic>ksharas</italic> gave satisfactory relief and <italic>chincha kshara</italic> gave relatively better result than <italic>kadalikshara</italic>. No advers effects of <italic>ksharas</italic> were seen during the clinical study period.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>In nutshell, on the basis of aforesaid parameters, it can be said that <italic>Chincha kshara</italic> was more effective than <italic>Kadali kshara</italic> due to its more alkaline nature. However, it is a humble attempt to give a scientific base to classical claim of <italic>kshara</italic> application with the limited facilities available so far. This can further be expanded and confirmed by suitable experimental study on the animals and taking a large sample to make it more scientific and effective.</p></sec></body><back><ack><title>Acknowledgment</title><p>It is indeed a pleasing privilege for us to conduct this study with the constant co-operation of patients and departmental staff. We express our heartiest thanks and indebtedness to them.</p></ack><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>Anantaram</given-names><suffix>Dr</suffix></name></person-group><source>Sushruta Samhita. Sutra Sthana</source><year>2006</year><volume>1</volume><edition>Reprint</edition><issue>05</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakasana</publisher-name><fpage>04</fpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Yadav</surname><given-names>T</given-names></name></person-group><article-title>Charaka Samhita. Sutra Sthana</article-title><source>Ayurdeva Dipika comm. of Chakrapani</source><year>1981</year><volume>1</volume><edition>4th ed</edition><issue>68-73</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Series</publisher-name><fpage>21</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Ambika Dutta</given-names></name></person-group><source>Sushruta Samhita., Sutra Sthana</source><year>1978</year><volume>11</volume><edition>5th ed</edition><issue>3</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Pratisthana</publisher-name><fpage>34</fpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Ambika Dutta</given-names></name></person-group><source>Sushruta Samhita., Sutra Sthana</source><year>1978</year><volume>11</volume><edition>5th ed</edition><issue>18</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Pratisthana</publisher-name><fpage>35</fpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Murty</surname><given-names>K. R. S.</given-names><suffix>Prof.</suffix></name></person-group><source>Asthanga Hridaya. Sutra Sthana</source><year>1991</year><volume>30</volume><edition>1st ed</edition><issue>24</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Series</publisher-name><fpage>347</fpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Yadav</surname><given-names>T</given-names></name></person-group><article-title>Charaka Samhita. Sutra Sthana</article-title><source>Ayurdeva Dipika comm. of Chakrapani</source><year>1981</year><volume>27</volume><edition>4th ed</edition><issue>306</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Series</publisher-name><fpage>170</fpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Ambika Dutta</given-names></name></person-group><source>Sushruta Samhita. Sutra Sthana</source><year>1978</year><volume>11</volume><edition>5th ed</edition><issue>7</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Pratisthana;</publisher-name><fpage>35</fpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Ambika Dutta</given-names></name></person-group><source>Sushruta Samhita. Sutra Sthana</source><year>1978</year><volume>11</volume><edition>5th ed</edition><issue>20</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Pratisthana;</publisher-name><fpage>36</fpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Yadav</surname><given-names>T</given-names></name></person-group><article-title>Charaka Samhita. Sutra Sthana</article-title><source>Ayurdeva Dipika comm. of Chakrapani</source><year>1981</year><volume>1</volume><edition>4th ed</edition><issue>110</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Series</publisher-name><fpage>22</fpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Tripathi</surname><given-names>Ravi Dutt</given-names><suffix>Prof</suffix></name></person-group><article-title>Charaka Samhita. Chikitsa Sthana</article-title><source>Vaidyamanoramahindi comm. of Acharya Vidyadharsuklaand</source><year>2007</year><volume>15</volume><edition>reprint</edition><issue>171-193</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Pratishathan</publisher-name><fpage>381</fpage><lpage>3</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Ambika Dutta</given-names></name></person-group><source>Sushruta Samhita. Sutra Sthana</source><year>1978</year><volume>11</volume><edition>5th ed</edition><issue>8</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Pratisthana</publisher-name><fpage>35</fpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Pandit Kasinath</given-names></name></person-group><source>Rasatarangini</source><year>1989</year><volume>14</volume><edition>Reprint</edition><issue>62-63</issue><publisher-loc>Delhi</publisher-loc><publisher-name>Motilal Banarashidas</publisher-name><fpage>338</fpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Ambika Dutta</given-names></name></person-group><source>Sushruta Samhita. Sutra Sthana</source><year>1978</year><volume>46</volume><edition>5th ed</edition><issue>160</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Pratisthana</publisher-name><fpage>199</fpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Nirmala</surname><given-names>Bramhananda Tripathi</given-names><suffix>Dr.</suffix></name></person-group><source>Ashtang Hridaya Chikista Sthana</source><year>2009</year><volume>15</volume><edition>reprint</edition><issue>46</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Prakasana</publisher-name><fpage>751</fpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Pandit Kasinath</given-names></name></person-group><source>Rasatarangini</source><year>1989</year><volume>14</volume><edition>Reprint</edition><issue>59-61</issue><publisher-loc>Delhi</publisher-loc><publisher-name>Motilal Banarashidas</publisher-name><fpage>337</fpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Yadav</surname><given-names>T</given-names></name></person-group><article-title>Charaka Samhita. Chikitsa Sthana</article-title><source>Ayurdeva Dipika comm. of Chakrapani</source><year>1981</year><volume>13</volume><edition>4th ed</edition><issue>171</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Series</publisher-name><fpage>526</fpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Ambika Dutta</given-names></name></person-group><source>Sushruta Samhita. Sutra Sthana</source><year>1978</year><volume>11</volume><edition>5th ed</edition><issue>21</issue><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Pratisthana</publisher-name><fpage>37</fpage></element-citation></ref></ref-list></back></article>